SAVARA INC (SVRA:NASDAQ)
$5.3 -0.02 (-0.3759%)
Analysed SAVARA INC (SVRA:NASDAQ) News Sources
Savara Announces Chief Financial and Administrative Officer Transition
08-06-2026
yahoo.com
What Insmed Stock's Premium Is Actually Buying
07-08-2026
trefis.com
Savara Inc. (SVRA) Reports Q1 Financial Results
22-05-2026
yahoo.com
Assessing Savara (SVRA) Valuation As Shares Cool After Strong Long Term Returns
08-06-2026
yahoo.com
What Savara Investors Should Know About This 580,187-Option Exercise and FDA Timeline
27-06-2026
fool.com
Here's Why You Should Add Savara Stock to Your Portfolio Now
22-07-2026
yahoo.com
Savara Announces European and Australian Patent Offices Have Granted Patents for the Liquid Formulation of MOLBREEVI*, Providing Protection in Europe and Australia Until March 2041
30-07-2026
yahoo.com
Savara Reports Second Quarter 2026 Financial Results and Provides Business Update
11-08-2026
yahoo.com
Savara Announces New Employment Inducement Grant
20-08-2026
yahoo.com
Savara Announces Encore Presentations of Results from the Phase 3 Clinical Trial of Molgramostim Inhalation Solution (Molgramostim) in Autoimmune Pulmonary Alveolar Proteinosis (APAP) at the European Respiratory Society (ERS) Congress 2026
24-08-2026
yahoo.com
What is the current price of SAVARA INC (SVRA:NASDAQ)?
The current price of SAVARA INC (SVRA:NASDAQ) is $5.3.
SAVARA INC (SVRA:NASDAQ) absolute price change since previous trading day?
The absolute price change of SAVARA INC (SVRA:NASDAQ) since the previous trading day is $-0.02.
SAVARA INC (SVRA:NASDAQ) percentage price change since previous trading day?
The percentage price change of SAVARA INC (SVRA:NASDAQ) since the previous trading day is -0.3759%.
What is the most recent average sentiment score for SAVARA INC (SVRA:NASDAQ)?
The most recent average sentiment score for SAVARA INC (SVRA:NASDAQ) is 76 out of 100.
What is the most recent average sentiment for SAVARA INC (SVRA:NASDAQ)?
The most recent sentiment for SAVARA INC (SVRA:NASDAQ) is .
SEC-8K** Filing Available For SAVARA INC (SVRA:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.